Thank you for your interest


Listen to the Podcast below or view a Transcript of the Podcast here


 


Parker Institute for Cancer Immunotherapy -Tumor Neoantigen Selection Alliance (TESLA)

Danny_WellsDanny Wells, Ph.D., Scientist, Informatics, Parker Institute for Cancer Immunotherapy

Danny Wells speaks to CHI on July 6th, 2017. Dr. Wells will be speaking during Neoantigen-Based Personalized Immunotherapies meeting at ImPACT: Immunotherapy Progress and Clinical Treatments, December 5-7th, 2018 in San Diego, California.

Topics Include: scaling up personalized therapies, future clinical applications of neoantigens, and new frontiers in cancer immunotherapy.

For more information, please visit www.ImpactImmunotherapy.com/Neoantigen-Immunotherapy/